M. Waki et al., Modulation by cAMP of 1 alpha,25-dihydroxyvitamin D-3 sensitivity of murine erythroleukemia cells, ARCH BIOCH, 391(2), 2001, pp. 265-270
As we previously reported, 1 alpha ,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3
) dose-dependently inhibited not only proliferation of undifferentiated mur
ine erythroleukemia (MEL) cells but also activin A-induced erythroid differ
entiation of MEL cells. However, the effect of 1,25(OH)(2)D-3 on MEL cell p
roliferation was significantly greater by one order of magnitude than that
on differentiation (IC50: 9.2 vs 0.8 nM, respectively). The response of act
ivin A-treated mature MEL cells to 1,25(OH)(2)D-3 in the induction of 1,25(
OH)(2)D-3-24-hydroxylase (24-OHase) activity, a rapid effect of 1,25(OH)(2)
D-3, was enhanced to the same degree as in untreated immature cells, sugges
ting that differences in capacity of cells to inactivate 1,25(OH)(2)D-3 did
not contribute to augmentation of 1,25(OH)(2)D-3 effect in activin A-treat
ed mature cells. Furthermore, neither the number nor the affinity of vitami
n D receptors (VDR) differed significantly between activin A-treated cells
and untreated immature cells. The intracellular cAMP level, which affects 1
,25(OH)(2)D-3-mediated induction of 24-OHase activity, was significantly le
ss in activin A-treated mature cells than in immature MEL cells. The additi
on of dibutyryl cAMP (dbc AMP) to activin A-treated MEL cells dose-dependen
tly attenuated 1,25(OH)(2)D-3-mediated induction of 24-OHase activity, fina
lly to a level comparable to that of the untreated cells at the final conce
ntration of 100 nM dbcAMP, while dbcAMP itself by 100 nM did not affect MEL
cell differentiation by 24 h.
In summary, we have shown for the first time that 1,25(OH)(2)D-3 exerted it
s effect on leukemia cells at physiological concentration and that the magn
itude of this effect depended on the changes in intracellular cAMP level th
rough stages of differentiation, suggesting that the cAMP-protein kinase A
system may be useful as a target for clinical application of vitamin D anal
ogs by improving the sensitivity of leukemic cells to 1,25(OH)(2)D-3. (C) 2
001 Academic Press.